However, compared with rats in T2DM group, BPS treatment efficiently reduced immunohistochemical expression of CD31, and integral optical density (IOD) of CD31 significantly decreased (Figures 5(a), 5(b), 5(c), and 5(d) and Table 6). The gene discussed is PECAM1; the disease is type 2 diabetes mellitus.